社论：世界卫生组织（WHO）修订的关于 SARS-CoV-2 的关注变体和感兴趣变体的术语。
Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.
机构信息
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Mellville, USA
出版信息
Med Sci Monit. 2021 Jun 21;27:e933622. doi: 10.12659/MSM.933622.
Abstract
The global pandemic of coronavirus disease 2019 (COVID-19) has identified thousands of genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On 31st May 2021, the Virus Evolution Working Group of the World Health Organization (WHO) announced its recommendations for revised naming of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs). This new nomenclature system may improve infection monitoring, infection control, and sharing of research data on viral genomics and epidemiology. This Editorial aims to present an update on the current revised WHO terminology for the genomic VOCs and VOIs of SARS-CoV-2.
摘要
全球 2019 年冠状病毒病（COVID-19）大流行已经确定了数千种严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的基因组序列。2021 年 5 月 31 日，世界卫生组织（WHO）病毒进化工作组宣布了修订的有关关注的严重急性呼吸综合征冠状病毒 2 变异株（VOCs）和感兴趣的变异株（VOIs）的命名建议。这一新的命名系统可能会改善对病毒基因组学和流行病学的感染监测、感染控制以及研究数据的共享。本社论旨在介绍 SARS-CoV-2 的基因组 VOCs 和 VOIs 的当前修订的 WHO 术语的最新情况。
相似文献
1
Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2.
Med Sci Monit. 2021 Jun 21;27:e933622. doi: 10.12659/MSM.933622.
2
The world needs a single naming system for coronavirus variants.
Nature. 2021 Jan;589(7842):330. doi: 10.1038/d41586-021-00105-z.
3
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse.
Nat Microbiol. 2021 Jul;6(7):821-823. doi: 10.1038/s41564-021-00932-w.
4
Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.
Emerg Infect Dis. 2021 Nov;27(11):2957-2960. doi: 10.3201/eid2711.211198. Epub 2021 Aug 26.
5
A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview.
J Med Virol. 2020 Sep;92(9):1634-1636. doi: 10.1002/jmv.25773. Epub 2020 Mar 27.
6
SARS-CoV-2 Variants of Concern.
Yonsei Med J. 2021 Nov;62(11):961-968. doi: 10.3349/ymj.2021.62.11.961.
7
Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
Med Sci Monit. 2022 Feb 1;28:e936199. doi: 10.12659/MSM.936199.
8
Genomic epidemiology and phylogenetics applied to the study of SARS-CoV-2 pandemic.
New Microbiol. 2023 Feb;46(1):1-8.
9
Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
Viruses. 2021 Jun 7;13(6):1087. doi: 10.3390/v13061087.
10
SARS-CoV-2 Mutations and COVID-19 Clinical Outcome: Mutation Global Frequency Dynamics and Structural Modulation Hold the Key.
Front Cell Infect Microbiol. 2022 Mar 21;12:868414. doi: 10.3389/fcimb.2022.868414. eCollection 2022.
引用本文的文献
1
Current Updates on Variants of SARS-CoV- 2: Systematic Review.
Health Sci Rep. 2024 Nov 4;7(11):e70166. doi: 10.1002/hsr2.70166. eCollection 2024 Nov.
2
Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants.
J Immunol Res. 2024 Jan 25;2024:9125398. doi: 10.1155/2024/9125398. eCollection 2024.
3
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity.
NPJ Vaccines. 2023 Oct 20;8(1):160. doi: 10.1038/s41541-023-00753-4.
4
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.
Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023.
5
Genome analysis of SARS-CoV-2 isolates from a population reveals the rapid selective sweep of a haplotype carrying many pre-existing and new mutations.
Virol J. 2023 Sep 1;20(1):201. doi: 10.1186/s12985-023-02139-3.
6
Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2.
Med Sci Monit. 2023 Sep 1;29:e942244. doi: 10.12659/MSM.942244.
7
An ARMS-Multiplex PCR Targeting SARS-CoV-2 Omicron Sub-Variants.
Pathogens. 2023 Aug 6;12(8):1017. doi: 10.3390/pathogens12081017.
8
Monitoring SARS-CoV-2 variants in wastewater of Dhaka City, Bangladesh: approach to complement public health surveillance systems.
Hum Genomics. 2023 Jul 7;17(1):58. doi: 10.1186/s40246-023-00505-4.
9
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol.
J R Soc Interface. 2023 Jun;20(203):20230062. doi: 10.1098/rsif.2023.0062. Epub 2023 Jun 21.
10
Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants.
Nutrients. 2023 Jun 5;15(11):2631. doi: 10.3390/nu15112631.
本文引用的文献
1
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse.
Nat Microbiol. 2021 Jul;6(7):821-823. doi: 10.1038/s41564-021-00932-w.
2
Genetic Variants of SARS-CoV-2-What Do They Mean?
JAMA. 2021 Feb 9;325(6):529-531. doi: 10.1001/jama.2020.27124.
3
Genomic sequencing effort for SARS-CoV-2 by country during the pandemic.
Int J Infect Dis. 2021 Feb;103:305-307. doi: 10.1016/j.ijid.2020.12.034. Epub 2020 Dec 14.
4
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
Nat Microbiol. 2020 Nov;5(11):1403-1407. doi: 10.1038/s41564-020-0770-5. Epub 2020 Jul 15.
Zotero 插件